Breast cancer cell lines are commonly categorized by the expression of clinical corresponding molecular markers, such as estrogen receptor (ER), ErbB2 receptor tyrosine kinase 2 (HER2), and epidermal growth factor receptor (EGFR)16. This evidence concerns the gene ESR1 and breast cancer.